Payment overview · 2025
General Payments
$101.19
2 reported records · 2 companies
Healthcare provider profile · identity verified
Rachel Vanwormer, NP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · SAINT HELEN, MI · NPI 1013366616
Verified facts
What the public records show
CMS Open Payments records show Rachel Vanwormer, NP received $101.19 in general payments during 2025 across 2 reported records.
Phathom Pharmaceuticals, Inc. accounted for 50.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $50.79 | 50.2% | 1 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $50.40 | 49.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $101.19 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $50.79 | 1 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $50.40 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 442 | 77 |
| Atorvastatin Calcium | Atorvastatin Calcium | 425 | 124 |
| Lisinopril | Lisinopril | 369 | 102 |
| Omeprazole | Omeprazole | 268 | 70 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 231 | 61 |
| Levothyroxine Sodium | Levothyroxine Sodium | 214 | 62 |
| Alprazolam | Alprazolam | 213 | 39 |
| Gabapentin | Gabapentin | 213 | 48 |
| Metformin Hcl | Metformin Hcl | 198 | 56 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 171 | 52 |
| Tramadol Hcl | Tramadol Hcl | 155 | 32 |
| Amlodipine Besylate | Amlodipine Besylate | 147 | 51 |
| Furosemide | Furosemide | 138 | 44 |
| Tamsulosin Hcl | Tamsulosin Hcl | 135 | 38 |
| Potassium Chloride | Potassium Chloride | 120 | 33 |
| Losartan Potassium | Losartan Potassium | 118 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 115 | 36 |
| Hydrochlorothiazide | Hydrochlorothiazide | 108 | 31 |
| Simvastatin | Simvastatin | 103 | 27 |
| Ozempic | Semaglutide | 99 | 20 |
| Pantoprazole Sodium | Pantoprazole Sodium | 96 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 86 | 29 |
| Jardiance | Empagliflozin | 85 | 25 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 83 | 20 |
| Montelukast Sodium | Montelukast Sodium | 81 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 79 | 38 |
| Trazodone Hcl | Trazodone Hcl | 73 | 19 |
| Allopurinol | Allopurinol | 70 | 19 |
| Meloxicam | Meloxicam | 70 | 24 |
| Baclofen | Baclofen | 69 | 23 |
| Eliquis | Apixaban | 68 | 22 |
| Carvedilol | Carvedilol | 67 | 25 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 67 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 65 | 18 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 64 | 12 |
| Mounjaro | Tirzepatide | 61 | 11 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 59 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 59 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 57 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 57 | 12 |
| Atenolol | Atenolol | 56 | 16 |
| Prednisone | Prednisone | 55 | 32 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 53 | 17 |
| Xarelto | Rivaroxaban | 52 | 12 |
| Ibuprofen | Ibuprofen | 51 | 21 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | 12 |
| Pregabalin | Pregabalin | 50 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 49 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 47 | 18 |
| Bupropion Xl | Bupropion Hcl | 45 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 44 | 17 |
| Farxiga | Dapagliflozin Propanediol | 44 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 43 | 13 |
| Buspirone Hcl | Buspirone Hcl | 41 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 41 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 41 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 39 | 12 |
| Sertraline Hcl | Sertraline Hcl | 39 | suppressed |
| Glipizide | Glipizide | 38 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 36 | 11 |
| Trulicity | Dulaglutide | 36 | 13 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 35 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 35 | 15 |
| Nitroglycerin | Nitroglycerin | 35 | 11 |
| Lorazepam | Lorazepam | 32 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 31 | suppressed |
| Famotidine | Famotidine | 30 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 29 | 11 |
| Ezetimibe | Ezetimibe | 28 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 28 | suppressed |
| Glimepiride | Glimepiride | 27 | suppressed |
| Diazepam | Diazepam | 26 | suppressed |
| Vraylar | Cariprazine Hcl | 26 | suppressed |
| Celecoxib | Celecoxib | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 24 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 23 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 23 | suppressed |
| Aripiprazole | Aripiprazole | 22 | suppressed |
| Clonazepam | Clonazepam | 22 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 22 | suppressed |
| Finasteride | Finasteride | 22 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 22 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 21 | suppressed |
| Fentanyl | Fentanyl | 20 | suppressed |
| Fluconazole | Fluconazole | 20 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 19 | suppressed |
| Januvia | Sitagliptin Phosphate | 19 | suppressed |
| Memantine Hcl | Memantine Hcl | 19 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 18 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Rinvoq | Upadacitinib | 17 | suppressed |
| Azithromycin | Azithromycin | 16 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Invokana | Canagliflozin | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 15 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Spironolactone | Spironolactone | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 14 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | 12 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 14 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 14 | suppressed |
| Bevespi Aerosphere | Glycopyrrolate/Formoterol Fum | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | 12 |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Repatha Sureclick | Evolocumab | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Butorphanol Tartrate | Butorphanol Tartrate | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Hydrocodone-Ibuprofen | Hydrocodone/Ibuprofen | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Dulera | Mometasone/Formoterol | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Febuxostat | Febuxostat | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $101.19 · 2 records | Phathom Pharmaceuticals, Inc. | Auvelity, VOQUEZNA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error